The Colossal Ambition: De extinction's $20 Billion Valuation Colossal Biosciences, a de extinction startup, is reportedly in talks to raise new capital at a valuation of $20 billion to $30 billion.
This development comes on the heels of a year where the company began generating revenue, spun out multiple startups, and made significant strides in conservation technology.
The astronomical valuation may stem from Colossal's promise of reviving long lost species or its potential for applying core science to various industries. The answer lies somewhere in between.